Diagnosis and treatment of fetal and pediatric age patients (0–12 years) with Wolff–Parkinson–White syndrome and atrioventricular accessory pathways-Reference-Cited by-同舟云学术

Diagnosis and treatment of fetal and pediatric age patients (0–12 years) with Wolff–Parkinson–White syndrome and atrioventricular accessory pathways

Published:2023-05-29 Issue:9 Volume:24 Page:589-601
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:

Author:

Leoni Loira¹,Bronzetti Gabriele²,Colonna Diego³,Porcedda Giulio⁴,Rimini Alessandro⁵,Silvetti Massimo Stefano⁶

Affiliation:

1. Cardiology, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, European Reference Network for Rare and Low Prevalence Complex Disease of the Heart (ERN GUARD-Heart), Padua

2. Cardio-Thoraco-Vascular Department, Sant’Orsola Hospital, University Hospital of Bologna IRCCS, Bologna

3. Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples

4. Unit of Pediatric Cardiology, Anna Meyer Children's Hospital, Florence

5. Giannina Gaslini Hospital IRCCS, Genoa

6. Pediatric Cardiology and Cardiac Arrhythmia/Syncope Unit, and Bambino Gesù Children's Hospital, IRCCS, European Reference Network for Rare and Low Prevalence Complex Disease of the Heart (ERN GUARD-Heart). Rome, Italy

Abstract

Overt or concealed accessory pathways are the anatomic substrates of ventricular preexcitation (VP), Wolff–Parkinson–White syndrome (WPW) and paroxysmal supraventricular tachycardia (PSVT). These arrhythmias are commonly observed in pediatric age. PSVT may occur at any age, from fetus to adulthood, and its symptoms range from none to syncope or heart failure. VP too can range from no symptoms to sudden cardiac death. Therefore, these arrhythmias frequently need risk stratification, electrophysiologic study, drug or ablation treatment. In this review of the literature, recommendations are given for diagnosis and treatment of fetal and pediatric age (≤12 years) WPW, VP, PSVT, and criteria for sport participation.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference90 articles.

1. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff–Parkinson–White (WPW, ventricular preexcitation) electrocardiographic pattern;Cohen;Heart Rhythm,2012

2. A proposed autosomal dominant method of inheritance of the Wolff–Parkinson–White syndrome and supraventricular tachycardia;Gillette;J Pediatr,1978

3. Familial Wolff–Parkinson–White syndrome;Chia;J Electrocardiol,1982

4. Familial hypertrophic cardiomyopathy with Wolff–Parkinson–White syndrome maps to a locus on chromosome 7q3;MacRae;J Clin Invest,1995

5. Identification of a gene responsible for familial Wolff–Parkinson–White syndrome;Gollob;N Engl J Med,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wolff-Parkinson-White Syndrome in the Preterm Neonate;Neonatal Network;2024-08-01

2. Antiarrhythmic therapy for narrow QRS supraventricular tachyarrhythmias in newborns and infants in the first year of life: Potent tools to be handled with care;Indian Pacing and Electrophysiology Journal;2024-07

3. Wolf–Parkinson–White Syndrome: Diagnosis, Risk Assessment, and Therapy—An Update;Diagnostics;2024-01-30